Search En menu en ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages
    Reference: 20240116
    Release date: 28 August 2024

    Promoter – Financial Intermediary

    LUMICKS TECHNOLOGIES BV

    Location

    Description

    The project will support the Research and Development investments (RDI) of Lumicks into development of next generation cell avidity and dynamic single-molecule instruments, allowing real-time analysis of molecular and cellular mechanisms and interactions. With large applications in fundamental and applied research, the new instruments can speed up and enhance success rates in drug discovery and development.

    Objectives

    The project supports the continued development, manufacturing scale-up and market access of Cellular Avidity and Dynamic Single Molecule instruments. These tools allow research institutions, biotech and pharma companies to conduct a more efficient rational drug design and development, ultimately giving more reliable in vitro results before entering in vivo models (clinical stage).

    Sector(s)

    Proposed EIB finance (Approximate amount)

    EUR 20 million

    Total cost (Approximate amount)

    EUR 46 million

    Environmental aspects

    The project concerns investments in research and development activities carried out by the promoter and its partners in existing facilities without changing their already authorised scope. The related RDI activities do not fall under either Annex I or Annex II of the Environmental Impact Assessment (EIA) Directive 2011/92/EU (amended by Directive 2014/52/EU). Full environmental details will be verified during appraisal.

    Procurement

    The EIB requires that all project contracts are procured in accordance with the applicable EU procurement legislation.

    Status

    Signed - 10/10/2024

    Milestone
    Under appraisal
    Approved
    Signed
    4 October 2024
    10 October 2024

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
    They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Related tags

    The Netherlands Industry Services